DXSN:F:F-Xtrackers - ShortDAX Daily Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 11.7

Change

-0.08 (-0.71)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.22 (-0.80%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.42 (-0.82%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

-9.16 (-1.53%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.10 (-0.63%)

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

-1.74 (-1.62%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-1.69 (-1.57%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.70 (-1.56%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

+0.08 (+1.05%)

USD 40.89B
0ZC:F Zscaler Inc

-8.14 (-4.11%)

USD 37.92B

ETFs Containing DXSN:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.73% 13% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.73% 12% F 38% F
Trailing 12 Months  
Capital Gain -11.44% 9% A- 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.44% 8% B- 32% F
Trailing 5 Years  
Capital Gain -38.33% 2% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.33% 2% F 24% F
Average Annual (5 Year Horizon)  
Capital Gain -9.98% 7% C- 21% F
Dividend Return -9.98% 7% C- 20% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.30% 54% F 84% B
Risk Adjusted Return -81.13% 5% F 10% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.